Back
State Street Financial Sel Sec SPDR ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
79
XLF
State Street Financial Sel Sec SPDR ETF
Last Price:
$54.63
Seasonality Move:
-1.45%
Buy
65
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.83
Seasonality Move:
-9.01%
Buy
79
State Street Financial Sel Sec SPDR ETF (XLF)
is a Buy
Is State Street Financial Sel Sec SPDR ETF a Buy, Sell or Hold?
-
The current State Street Financial Sel Sec SPDR ETF [XLF] share price is $54.63. The Score for XLF is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
XLF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XLF Stock Price Chart
What is State Street Financial Sel Sec SPDR ETF's stock price today?
-
The State Street Financial Sel Sec SPDR ETF share price today is $54.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
XLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.36 | Buy |
| Relative Strength Index (14 RSI): | 63.29 | Buy |
| Chaikin Money Flow: | -32737187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.98 - 54.28) | Buy |
| Bollinger Bands (100): | (52.19 - 53.89) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.92 | Buy |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | -264527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.99 - 110.55) | Buy |
| Bollinger Bands (100): | (94.91 - 108.39) | Buy |
XLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.34 | Buy |
| 20-day SMA: | 53.32 | Buy |
| 50-day SMA: | 52.91 | Buy |
| 200-day SMA: | 51.54 | Buy |
| 8-day EMA: | 12.14 | Buy |
| 20-day EMA: | 5.2 | Buy |
| 50-day EMA: | 2.14 | Buy |
| 200-day EMA: | 0.54 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.83 | Buy |
| 20-day SMA: | 106.87 | Buy |
| 50-day SMA: | 105.94 | Buy |
| 200-day SMA: | 82.62 | Buy |
| 8-day EMA: | 24.86 | Buy |
| 20-day EMA: | 10.65 | Buy |
| 50-day EMA: | 4.39 | Buy |
| 200-day EMA: | 1.11 | Buy |
State Street Financial Sel Sec SPDR ETF Earnings Growth & XLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
State Street Financial Sel Sec SPDR ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||